Cytokinetics Inc vs Heron Therapeutics Inc — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: Cytokinetics Inc is far larger — about 172.9× Heron Therapeutics Inc's market cap, and Cytokinetics Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| CYTK | HRTX | |
|---|---|---|
Market Cap | $10.63B | $61.47M |
Sector | Technology | Health |
52-Week High | $87.26 | $1.49 |
52-Week Low | $34.31 | $0.32 |
Enterprise Value | $10.74B | $168.21M |
Trailing returns across standard periods
Latest headlines on both assets
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →